Local Institution

Worcester, Massachusetts 01608

0 studies enrolling now · 8 studies all time

What they study most

Body Weight Change, Diabetes Mellitus II, Multiple Myeloma, Multiple Sclerosis, Psychotic Disorder, Rheumatoid Arthritis, Schizoaffective Disorder, Schizophrenia, Type 2 Diabetes

Studies at this site

• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder — Completed
• Abatacept With Methotrexate- Phase IIB — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis — Stopped early
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed